Related Experiment Video

Updated: Jun 15, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference

Shaochuang Wang1, Hui Liu, Lifeng Ren

  • 1National Hepatobiliary and Enteric Surgery Research Center, Ministry of Health, Central South University, Hunan Province, 410008, People's Republic of China.

Neoplasia (New York, N.Y.)
|April 9, 2008
PubMed

Insights

RNA interference targeting vascular endothelial growth factor (VEGF) effectively suppressed colorectal cancer cell growth and metastasis in preclinical models. This anti-angiogenic strategy shows promise for treating this common cancer type.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Angiogenesis is crucial for tumor progression and metastasis, making it a key therapeutic target.
  • Vascular endothelial growth factor (VEGF) is a primary regulator of angiogenesis.
  • RNA interference (RNAi) offers a potential method to target VEGF-driven tumor growth.

Purpose of the Study:

  • To investigate the role of VEGF in colorectal carcinoma (CRC) tumor growth and metastasis.
  • To evaluate the efficacy of RNA interference (RNAi) targeting VEGF using small interfering RNA (siRNA).

Main Methods:

  • Four VEGF-specific siRNA sequences were designed and cloned into expression plasmids.
  • Human colorectal carcinoma (CRC) SW620 cells were stably transfected with these plasmids.
  • Tumorigenicity and metastasis were assessed in vitro and in athymic nude mouse models.

Main Results:

  • Stable transfection significantly reduced VEGF protein expression in SW620 cells.
  • VEGF siRNA suppressed tumor cell proliferation, migration, invasion, and angiogenesis in vitro.
  • Tumor growth and metastasis were significantly inhibited in mice receiving VEGF siRNA-expressing cells.
  • Immunohistochemistry confirmed reduced vessel density and VEGF expression in tumors.

Conclusions:

  • RNA interference targeting VEGF is a potent strategy for inhibiting colorectal cancer growth and metastasis.
  • This anti-angiogenic approach holds significant therapeutic potential for colorectal cancer treatment.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...